← Browse by Condition
Medical Condition

cognitive change

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for cognitive change sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cognitive change Clinical Trials

How many clinical trials are currently recruiting for cognitive change?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cognitive change, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognitive change?
cognitive change research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognitive change clinical trial?
Eligibility criteria for cognitive change trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Chang Gung Memorial Hospital 1 trial
University of Florida 1 trial
Second Affiliated Hospital, Zhejiang University, School of Medicine 1 trial
UNC Lineberger Comprehensive Cancer Center 1 trial
University of North Carolina, Greensboro 1 trial

Recruiting Clinical Trials

NCT07414680
Recruiting
Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4
Enrollment
250 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
View Trial →
NCT05457725
Recruiting
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
Enrollment
68 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05922137
Recruiting
Oriental Intervention for Enhanced Neurocognitive Health (ORIENT) Diet in Patients With Intracranial / Carotid Stenosis
Enrollment
120 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
View Trial →
NCT06727773 Phase 2
Recruiting
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
View Trial →
NCT04861818
Recruiting
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
Enrollment
80 pts
Location
United States
Sponsor
University of North Carolina, ...
View Trial →

Related Conditions

aging (2) cognitive decline (2) sleep disturbance (1) neurocognitive disorders mild (1) stenosis (1) dementia (1) breast cancer (1) locally advanced breast cancer (1) cognitive impairment (1) breast cancer stage i (1) breast cancer stage ii (1) breast cancer stage iii (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology